MOLLY DAVIS: Open Payments
NPI 1124547435 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 42 payments from 13 companies in 2025. Trend: 2023 $2,515 · 2024 $2,374 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $339 |
| PFIZER INC. | 3 | $70 |
| Janssen Biotech, Inc. | 2 | $38 |
| Corcept Therapeutics | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| QOL Medical, LLC | 1 | $16 |
Products named: LINZESS, VRAYLAR, SKYRIZI, TREMFYA, RINVOQ, Korlym, CREON, IBRANCE.
Industry payments across OH — which companies pay providers there.
